Religare Enterprises Ltd

Religare Enterprises Other Announcement

Religare Enterprises Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026, as per SEBI requirements.

Religare Enterprises Merger & Restructuring Worth ₹119.7 Cr

Religare Enterprises subscribed to a rights issue by its subsidiary, Care Health Insurance, for Rs. 119.69 Crore. The investment supports the subsidiary's expansion and solvency requirements.

Value

₹119.7 Cr

Religare Enterprises Management Change

Religare Enterprises approved the continuation of Mr. Rajender Mohan Malla as Non-Executive Chairperson. His term is extended for the July-September 2026 quarter on a rotational basis.

Execution

July 01, 2026 to September 30, 2026

Religare Enterprises Merger & Restructuring

Religare Enterprises received 'no objection' for its demerger scheme. The restructuring, subject to statutory approvals, aims to separate its businesses.

Religare Enterprises Credit Rating

ICRA has reaffirmed the [ICRA]BBB- (Stable) rating for Religare Housing's bank lines. The rating applies to a rated amount of ₹400 Crore.

Value

₹400.0 Cr

Religare Enterprises Management Change

Religare Enterprises appointed Pavan Kumar Gupta as MD and CEO of its subsidiary RHDFCL. The appointment is effective from July 1, 2026.

Religare Enterprises Capital Structure Change

Religare Enterprises Limited allotted 83,43,263 equity shares following the conversion of warrants. This increases the company's total paid-up share capital to 34,12,33,742 shares.

Religare Enterprises Capital Structure Change

Religare Enterprises allotted 83,43,263 equity shares following warrant conversions, receiving ₹147.05 Crore in funds. This conversion increases the company's total paid-up share capital.

Value

₹147.1 Cr

Religare Enterprises Capital Structure Change

Religare Enterprises allotted 83,43,263 equity shares following warrant conversions, totaling ₹196.07 Crore. The allotment increases paid-up capital and concludes the 18-month warrant exercise period.

Value

₹196.1 Cr

Religare Enterprises Results Correction

Religare Enterprises clarified an inadvertent 'audited' selection in its Q4FY26 XBRL financial results filing. The company is taking steps to submit corrected forms to the exchange.

Religare Enterprises Earnings Call: Key Takeaways

Religare Enterprises reported FY26 consolidated total income of ₹8,493cr and PAT of ₹73.16cr. Management is restructuring via demerger into two listed entities: Health Insurance and Financial Services.

Religare Enterprises Management Change

Religare Enterprises designated Group General Counsel Babu Rao Priya as Key Managerial Personnel. The move strengthens corporate governance and formalizes senior leadership responsibilities.

Religare Enterprises Fund Raise of ₹1,500 Cr

Religare Enterprises Limited filed its monitoring report for the ₹1,500.00 Crore warrant issue proceeds. The agency confirmed utilization aligns with specified objects without deviations.

Value

₹1,500 Cr

Execution

September 12, 2025 to March 11, 2027